GATA2 and leukemia: Further studies revealed that CEBPA mutations enhance its ability to bind and regulate the GATA2 enhancer, working in conjunction with TET2 mutations to rebalance GATA2 expression levels, thereby conferring greater competitiveness and aggressiveness to leukemia cells [15].